🔎 Trials Near Me

Home › T-Cell Lymphoma › Washington › Seattle

Pag-aaral pangklinika para sa T-Cell Lymphoma sa Seattle, WA

6 pag-aaral para sa T-Cell Lymphoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Seattle (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

Nagre-recruitPhase 2
  • Fred Hutchinson Cancer Center, Seattle
  • University of Washington Medical Center - Montlake, Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT04803201

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

Nagre-recruitPhase 3
  • University of Washington Fred Hutch Cancer Center, Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06561048

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Nagre-recruitPhase 3
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06724237

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Nagre-recruitPhase 1/2
  • Swedish Cancer Institute, Seattle
  • Fred Hutchinson Cancer Center, Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT04104776

Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma

Nagre-recruitPhase 1/2
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Edad 18 pataas · Lahat ng kasarian · Na-update May 11, 2026 · NCT07225985

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Nagre-recruitPhase 1
  • Seattle Children's Hospital, Seattle
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Dis 6, 2024 · NCT05476770

Pag-aaral para sa T-Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Seattle

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.